Early combination of bromocriptine and levodopa in the treatment of Parkinson's disease: a 5-year follow-up.
about
The alpha2-adrenergic receptor antagonist idazoxan reduces dyskinesia and enhances anti-parkinsonian actions of L-dopa in the MPTP-lesioned primate model of Parkinson's diseaseParkinson's disease--levodopa complications.Rationale for use of dopamine agonists in Parkinson's disease: review of ergot derivatives.A randomised controlled study comparing bromocriptine to which levodopa was later added, with levodopa alone in previously untreated patients with Parkinson's disease: a five year follow up.The initial treatment of Parkinson's disease should begin with levodopa.Treatment of Parkinson's disease should begin with a dopamine agonist.Effects of combined MAO-B inhibitors and levodopa vs. monotherapy in Parkinson's disease.Idiopathic Parkinson's disease: epidemiology, diagnosis and management.Parkinson's Disease: Initial Treatment with Levodopa or Dopamine Agonists.How to optimize the treatment of early stage Parkinson's disease.Parkinson's disease therapeutics: new developments and challenges since the introduction of levodopa.Dopamine agonists in the treatment of Parkinson's disease.Drug treatment of Parkinson's diseaseComparison of the clinical pharmacology of (-)NPA and levodopa in Parkinson's diseaseRole of dopamine agonists in Parkinson's disease: an update.Back to the tubule: microtubule dynamics in Parkinson's disease.The modern management of Parkinson's disease.Milestones in Parkinson's disease therapeutics.Drug management of Parkinson's disease.Drug treatment of Parkinson's disease: is "polypharmacy" best?Early combination therapy with bromocriptine and levodopa in Parkinson's disease.Is striatal dopaminergic receptor imbalance responsible for levodopa-induced dyskinesia?Optimal drug management of Parkinson's disease.Bromocriptine lessens the incidence of mortality in L-dopa-treated parkinsonian patients: prado-study discontinued.Antiparkinsonian activity and dyskinesia risk of ropinirole and L-DOPA combination therapy in drug naïve MPTP-lesioned common marmosets (Callithrix jacchus).Early dopamine agonist therapy in Parkinson's disease.The rabbit syndrome.The effects of chronic levodopa treatment on pre- and postsynaptic markers of dopaminergic function in striatum of parkinsonian monkeys.Therapeutic advances in idiopathic Parkinsonism.Dyskinesias and motor fluctuations in Parkinson's disease. A community-based study.Ropinirole versus bromocriptine in the treatment of early Parkinson's disease: A 6-month interim report of a 3-year studyRopinirole in the treatment of early Parkinson's disease: A 6-month interim report of a 5-year levodopa-controlled study
P2860
Q28373127-E806FAEA-10C7-44EF-B0BE-3A607099C045Q33714114-48D040F9-2BE2-4586-92D3-E49CBE55331CQ33714121-04AC80C6-55D0-4FFF-A87B-2CF4FDF8FB40Q33733049-864ACE7F-72DE-49E3-A608-672F127087DDQ33737387-62E8FC06-A5D0-4717-BFA6-7F3853A1D009Q33737392-54AE1F92-9CDE-448A-BC37-FA9683722341Q33950517-D4B7B608-2F73-4682-93C9-904BB00363C0Q34053847-F60B20B4-D28C-45F6-918B-D8D896D1E0D4Q34388170-BAA7B942-33E6-4A52-BCF4-65921DC7358CQ35599297-235E444A-3847-4FE4-B6AE-8F0AC60767C2Q35614156-301D6EA3-277B-4E9E-AC2A-A1D8C0B975C7Q36390870-ECDD6D76-A82F-4168-AC3A-D38BBDA92914Q36902632-E05A71C4-CF04-4AF7-87DF-DD56B59E8581Q36947508-009FF5BC-3797-4455-8C56-C90E169DD100Q36972701-A3811CAF-60EA-4864-A26F-09F53728EE5BQ37590635-72CFF1DB-0BB3-4A2A-8710-C4D8C00019B5Q37809006-34571720-4E50-4805-AB6F-EBEB8E106C1BQ37882596-5D156495-2034-495F-8095-811FBEF0FC89Q39113867-4A00FEDC-0F52-4A32-9E94-B511C719D47EQ40743476-3EDB1AA0-B992-4DEC-83E7-39EA156D939FQ40830113-6DC9CACD-4C4E-4D2B-BE8C-312E667F28F9Q40980387-B1AEAC77-1DD8-41A2-88E8-B382F2A51E43Q42580372-3B28DE81-3BDF-4411-AC23-8DC63E0A2586Q43521470-16C9C6E8-7513-4D39-AA96-2B01EB1C526EQ43693344-4B3C8DF2-2169-46B7-A825-6C3253D2C222Q44208711-0038DD0C-1B2B-41AF-BDDE-5BA2BC7EC9BAQ44378446-C2DF6391-5177-4692-94BA-95704D2DD671Q48786066-4B6BB9DB-4C1C-4526-9D3D-1D8963FB3685Q49115429-16EBED28-87F8-4804-AAD5-AB3D8F7DF550Q53509756-11199532-E271-40E3-AE03-786776BE67E8Q57089180-A712B7D7-0600-4872-B22A-C3D5FAA2003FQ57089195-FDC35740-A5EE-465E-A20E-F414526103A9
P2860
Early combination of bromocriptine and levodopa in the treatment of Parkinson's disease: a 5-year follow-up.
description
1987 nî lūn-bûn
@nan
1987年の論文
@ja
1987年学术文章
@wuu
1987年学术文章
@zh-cn
1987年学术文章
@zh-hans
1987年学术文章
@zh-my
1987年学术文章
@zh-sg
1987年學術文章
@yue
1987年學術文章
@zh
1987年學術文章
@zh-hant
name
Early combination of bromocrip ...... s disease: a 5-year follow-up.
@en
Early combination of bromocrip ...... s disease: a 5-year follow-up.
@nl
type
label
Early combination of bromocrip ...... s disease: a 5-year follow-up.
@en
Early combination of bromocrip ...... s disease: a 5-year follow-up.
@nl
prefLabel
Early combination of bromocrip ...... s disease: a 5-year follow-up.
@en
Early combination of bromocrip ...... s disease: a 5-year follow-up.
@nl
P356
P1433
P1476
Early combination of bromocrip ...... s disease: a 5-year follow-up.
@en
P2093
P304
P356
10.1212/WNL.37.5.826
P407
P577
1987-05-01T00:00:00Z